Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis

Bibliographische Detailangaben
Hauptverfasser:	Haotian Ma, Hongcheng Jiang, Jing Feng, Yong Gan
Format:	Artikel
Sprache:	English
Veröffentlicht:	Hindawi-Wiley 2021-01-01
Schriftenreihe:	Cardiovascular Therapeutics
Online Zugang:	http://dx.doi.org/10.1155/2021/6628469

Angiotensin&nbsp;II receptor blockers in the prevention of complications from atrial fibrillation
von: Gerald V Naccarelli, et al.
Veröffentlicht: (2009-09-01)

Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention
von: Cesare Cuspidi, et al.
Veröffentlicht: (2008-02-01)

A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
von: Ji-Guang Wang
Veröffentlicht: (2009-07-01)

Long-term observation of fibrillation cycle length in patients under angiotensin II receptor blocker therapy for chronic atrial fibrillation
von: Jun Kishihara, et al.
Veröffentlicht: (2012-02-01)

Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension
von: E. V. Kokhan, et al.
Veröffentlicht: (2021-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
von: O. M. Drapkina, et al.
Veröffentlicht: (2014-07-01)

Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery
von: Weiss Michael J, et al.
Veröffentlicht: (2010-02-01)

Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New‐Onset Atrial Fibrillation After Acute Myocardial Infarction
von: Gorav Batra, et al.
Veröffentlicht: (2017-03-01)

Termination of Aconitine-Induced Atrial Fibrillation by the KACh-Channel Blocker Tertiapin: Underlying Electrophysiological Mechanism
von: Kazumasa Suzuki, et al.
Veröffentlicht: (2014-01-01)

Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation
von: Nicole Habel, et al.
Veröffentlicht: (2023-06-01)

Effect of β-blockers on the risk of atrial fibrillation in patients with acute myocardial infarction
von: Antonio Eduardo Pesaro, et al.
Veröffentlicht: (2010-01-01)

Calcium channel blockers, more than diuretics, enhance vascular protective effects of angiotensin receptor blockers in salt-loaded hypertensive rats.
von: Eiichiro Yamamoto, et al.
Veröffentlicht: (2012-01-01)

Organization of atrial fibrillation using a pure sodium channel blocker: Implications of rotor ablation therapy
von: Tadafumi Nanbu, et al.
Veröffentlicht: (2023-06-01)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
von: Hyun Woong Lee
Veröffentlicht: (2014-12-01)

Correction: Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
Veröffentlicht: (2013-01-01)

Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes
von: Nishida Yayoi, et al.
Veröffentlicht: (2012-05-01)

The haemodynamic changes associated with treatment of new-onset atrial fibrillation with amiodarone or beta blockers
von: Bedford, J, et al.
Veröffentlicht: (2021)

Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation
von: Yanhua Yang, et al.
Veröffentlicht: (2020-01-01)

Acute Management of Paroxysmal Atrial Fibrillation with Intravenous Flecainide plus Oral Beta-Blockers
von: Athanasios Kartalis, et al.
Veröffentlicht: (2024-06-01)

Which beta-blocker should be used for the prevention of postoperative atrial fibrillation in cardiac surgery? A multi-treat
von: Mohamed Zeinah, et al.
Veröffentlicht: (2016-06-01)

Novel beta-blocker pretreatment prevents alcohol-induced atrial fibrillation in a rat modelKey Findings
von: Hebah Hassan, BS, et al.
Veröffentlicht: (2020-06-01)

The use of angiotensin receptor blockers in dementia prevention
von: Jordana de Araujo Müller, et al.
Veröffentlicht: (2023-09-01)

Effect of angiotensin receptor-neprilysin inhibitor on atrial electrical instability in atrial fibrillation
von: Tianyu Zhu, et al.
Veröffentlicht: (2022-12-01)

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: An individual-patient data meta-analysis
von: Kotecha, D, et al.
Veröffentlicht: (2014)

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
von: Kotecha, D, et al.
Veröffentlicht: (2014)

Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction
von: Akif Arslan, et al.
Veröffentlicht: (2016-01-01)

Effects of Angiotensin Receptor Blockers on Apelin and Visfatin in Hypertension
von: Mina Mohammed, et al.
Veröffentlicht: (2024-06-01)

Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
von: Yen-Chung Lin, et al.
Veröffentlicht: (2017-01-01)

COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT)
von: O. V. Dralova, et al.
Veröffentlicht: (2016-01-01)

Effect of angiotensin II receptor blockers and calcium antagonists on cognition
von: O. D. Ostroumova, et al.
Veröffentlicht: (2016-12-01)

β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis
von: Tianyu Xu, et al.
Veröffentlicht: (2019-06-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
von: M. A. Maksimova, et al.
Veröffentlicht: (2015-09-01)

Real-world efficacy of fimasartan vs. other angiotensin receptor blockers in combination with calcium channel blockers: a nationwide cohort study
von: Huijin Lee, et al.
Veröffentlicht: (2024-10-01)

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
von: Volpe M, et al.
Veröffentlicht: (2012-06-01)

Differential Effects in Cardiovascular Markers between High-Dose Angiotensin II Receptor Blocker Monotherapy and Combination Therapy of ARB with Calcium Channel Blocker in Hypertension (DEAR Trial)
von: Kenichiro Kinouchi, et al.
Veröffentlicht: (2011-01-01)

Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up
von: Han Saem Jeong, et al.
Veröffentlicht: (2021-01-01)

Lowering serum homocysteine in H-type hypertensive patients with atrial fibrillation after radiofrequency catheter ablation to prevent atrial fibrillation recurrence
von: Youzheng Dong, et al.
Veröffentlicht: (2022-09-01)

Managing postoperative atrial fibrillation after open-heart surgery using transdermal β1 blockers
von: Kenji Yamamoto, et al.
Veröffentlicht: (2023-04-01)

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis

Ähnliche Einträge

Ähnliche Einträge